EQS derivation for proposed priority substances WG E Chemical Aspects Brussels 21-22 October 2010 Agenda Item 5.2(b) Helen Clayton WFD Team DG Environment European Commission
Substances for which EQS dossiers are finalised or close to finalisation Bifenox (Possible revision of MAC-QS if full outdoor mesocosm study…) Dichlorvos (BPD TM Nov 2010) Dicofol (Check original pesticides dossier?) Heptachlor (Double-check coverage of endocrine-disrupting effects by AF) Terbutryn (DK comment to be addressed)
Substances for which EQS dossiers are advanced but complex Dioxin (Biota and sediment EQS proposed; corresponding water EQS to be debated) Note: Dioxin-like PCBs covered in Dioxin dossier – non-dioxin-like PCBs not yet dealt with; paper awaited. HBCDD (Biota EQS proposed; use of TMF studies to set corresponding water EQS under consideration) 17-alpha ethinylestradiol (Dossier being revised to derive single EQS cf range) PFOS (Questions re AF to be considered)
Substances for which dossiers are advanced but there are divergent opinions Aclonifen (Persistence?) Cybutryne (Reliability of low-end-point study) Cypermethrin (Studies to include? AF for MAC? Sediment EQS? Representativeness of monitoring data) Diclofenac (Appropriateness of using histopathological end-points?) NB Statement Paper from some Members Quinoxyfen (PBT properties?)
Dossier for which more data-gathering proposed to set EQS Cyanides - Industry proposes to commission plant and insect studies to support SSD – SG-R invited to comment on protocol; - More information needed on background concentrations and extent to which monitoring data represents free cyanide)
« Grey » substances Dossier advanced Zinc Dossiers still awaited 17 beta-estradiol (Dossier imminent – was awaiting industry PNEC paper) Ibuprofen (Data awaited on DE fish study – October)